DataMeds AI, Inc. (MEDS): Total Assets
$30.46M
As of 2025-12-31
$32.76M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $30.46M | -46.9% | 2026-03-20, Balance as of period end |
| 2024-12-31 | $57.33M | n/m | 2026-03-20, Balance as of period end |
| 2023-12-31 | $338.4K | n/a | 2025-03-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| DataMeds AI, Inc. (MEDS) | 2025-12-31 | $30.46M | -46.9% |
| Cosmos Health Inc. (COSM) | 2025-12-31 | $65.48M | +20.6% |
| Stemtech Corp (STEK) | 2025-12-31 | $3.15M | -16.7% |
| HWH International Inc. (ESYN) | 2025-12-31 | $4.57M | -28.7% |
| Nu Skin Enterprises, Inc. (NUS) | 2025-12-31 | $1.41B | -4.3% |
| Herbalife Ltd. (HLF) | 2025-12-31 | $2.79B | +2.1% |
| Cardinal Health Inc (CAH) | 2026-06-30 | $57.30B | +7.9% |
| Cencora, Inc. (COR) | 2025-09-30 | $76.59B | +14.1% |
| McKesson Corp (MCK) | 2026-03-31 | $82.32B | +9.6% |
Compare MEDS, COSM, STEK, ESYN side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗